Out of drug marketing on the error.doc

 PAGE \* MERGEFORMAT 5 Out of drug marketing on the error Paper Network: At present, some pharmaceutical companies seem to carry out product marketing into a misunderstanding, high input, high production, the concept of speculation and other marketing idea is popular, the original number of simple marketing methods are being forgotten by some marketers. In theory, marketing Innovation is a must, but also many pharmaceutical companies are keen, however, many of Trader are the name of ‘innovation’ on the cover, but during the marketing of the game, toss down effect is not obvious which problems, pharmaceutical companies should arouse enough attention to marketing resources and market opportunities to avoid waste. High input and low level of homogenization of the product the market more competitive, so some pharmaceutical companies began to focus on some of the popular new mode of operation, or in a number of generic drugs in the ‘support’ a priority species, or to an old drug into the market again after a face-lift this time, they rely on marketing to make up the difference of the lack of product homogeneity, and marketing strategy therefore is very important. pharmaceutical companies in the high-cost operation of the process is often easy to overlook the operation of the standards, appear to innovation, because the low level operation, it is hard to have satisfactory results. Pharmaceutical companies should follow the ‘low cost high quality’ of the operating principles, hire celebrities to advertise the product to take into account the characteristics and adapt to the crowd, according to the demand characteristics of the target population to choose a celebrity personality, in order to facilitate real play celebrity. operation of the product, the capacity to analyze the products in the market and prospects for development, and to determine the appropriate marketing strategy to take the blind promotional gifts, promotional and other means of hig